Project Grant R01CA285216
Award Date
9/1/24
Completion Date
8/31/29
Dollars Obligated
$1M
Federal Agency
National Cancer Institute
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
The National Cancer Institute (NCI) awarded a $257,415 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to The Research Foundation for the State University of New York (RF SUNY) to develop an AI-enhanced smartphone app-based intervention for adolescent e-cigarette cessation. The goal is to create a scalable, cost-effective intervention that uses AI-assisted user profiling and personalized content to help adolescents quit e-cigarettes. The 3-year project will...
This $687,995 federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports a randomized clinical trial to investigate the efficacy of varenicline, an FDA-approved smoking cessation medication, for quitting e-cigarette use in adults. The study, led by Yale University, aims to compare quit rates between varenicline and placebo among adults who report exclusive daily e-cigarette use, with or without a history of cigarette smoking....
This Project Grant award for $705,618 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program aims to develop and evaluate an innovative virtual reality (VR)-based e-cigarette prevention intervention called "E-Invite Only VR." The intervention targets emotion regulation skills as a risk factor for youth e-cigarette use, and will be optimized through iterative user-centered design with community partners. The project will then...
This federal Project Grant award, valued at $1,698,536.00 and provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, supports the development and testing of a remote, digital, and behavioral intervention called "QuitVaping" to promote nicotine vaping cessation and prevent escalation of tobacco use among youth. The project, led by the General Hospital Corporation (doing business as Massachusetts General Hospital), aims to...
This federal Project Grant award for $625,201 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports a randomized factorial trial to evaluate the effectiveness of combining varenicline with nicotine lozenges and a smartphone medication adherence intervention to promote smoking cessation. The study aims to enroll 496 adult smokers and assess 7-day point prevalence abstinence at 26 weeks and medication adherence over the 13-week...
This Project Grant award, funded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, supports a research project to identify key features of e-cigarette-related social media posts that are associated with high user engagement. The goal is to provide guidance for designing effective vaping prevention messages for future public health campaigns to help communicate the risks of e-cigarette use and prevent youth and young adult initiation...
This $310,319 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program will support the University of Louisville in conducting formative research to develop a motivation-based adolescent vaping typology to inform the development of tailored cognitive behavioral e-cigarette cessation interventions. The key objectives are to: 1) identify different types of adolescent e-cigarette users based on their motivations for use, 2)...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to the Regents of the University of California, San Francisco will provide $692,872 to develop and evaluate a scalable social media-based vaping cessation program for adolescents. The project, titled "Social Media Support Groups for Adolescent Vaping Cessation," will adapt the existing "Quit the Hit" program into a toolkit (QTHT) that can be implemented...
This $316,873 Project Grant awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports the development and pilot testing of a smartphone app version of the evidence-based "Libre del Cigarrillo" smoking cessation intervention for Spanish-speaking individuals. The key goals are to: 1) adapt the existing validated printed smoking cessation intervention for Spanish-speakers into a smartphone app format, and 2) conduct a...
The National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) awarded a $247,433 Project Grant to the University of Nebraska Medical Center (UNMC) for the "Parents Helping Parents for Youth Vaping Cessation (PHP-VX)" program. The goal of this feasibility study is to develop and test a parent-facilitated youth vaping cessation intervention, which will include online training sessions and weekly parent-to-parent support. A key sub-award of $34,102 was made to the...